CARGO Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
CARGO Therapeutics has a total shareholder equity of $400.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $451.0M and $50.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$404.85m |
| Equity | US$400.88m |
| Total liabilities | US$50.08m |
| Total assets | US$450.96m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CRGX's short term assets ($410.0M) exceed its short term liabilities ($21.6M).
Long Term Liabilities: CRGX's short term assets ($410.0M) exceed its long term liabilities ($28.4M).
Debt to Equity History and Analysis
Debt Level: CRGX is debt free.
Reducing Debt: CRGX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRGX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CRGX has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 70.6% each year.